Wall Street analysts expect Cross Country Healthcare (CCRN) to post quarterly earnings of $0.27 per share in its upcoming report, which indicates a year-over-year decline of 75.2%. Revenues are ...
Fintel reports that on March 5, 2026, Benchmark upgraded their outlook for Cross Country Healthcare (NasdaqGS:CCRN) from Hold to Buy. Analyst Price Forecast Suggests 27.10% Upside As of February 25, ...